CareDx Raises Guidance on Strong Q3 Test Volume Growth, Revenue Per Test
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- CDNA CareDx+32.8% 16d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that CareDx belongs to, so it often moves with news about it.
- NTRA Natera+15.8% 30d
Natera is a peer of CareDx in medical laboratories; rivals often move on the same news.
- LH Labcorp Holdings+14.3% 30d
Labcorp Holdings is a peer of CareDx in medical laboratories; rivals often move on the same news.
- DGX Quest Diagnostics+4.6% 30d
Quest Diagnostics is a peer of CareDx in medical laboratories; rivals often move on the same news.
- GH Guardant Health-3.0% 10d
Guardant Health is a peer of CareDx in medical laboratories; rivals often move on the same news.
- CAI Caris Life Sciences+19.5% 30d
Caris Life Sciences is a peer of CareDx in medical laboratories; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CDNA | -3.20% | -1.30% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| NTRANo price data for this ticker | — | — | — | — | — | — | — |
| LHNo price data for this ticker | — | — | — | — | — | — | — |
| DGXNo price data for this ticker | — | — | — | — | — | — | — |
| GHNo price data for this ticker | — | — | — | — | — | — | — |
| CAINo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
CareDx Raises Guidance on Strong Q3 Test Volume Growth, Revenue Per Test GenomeWeb
Source: GenomeWeb
This story
| Company | When | Move | Status |
|---|---|---|---|
| CDNA | three days earlier | -1.30% | final price |
| CDNA | five days earlier | -3.20% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Labcorp Holdings (LH) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $100,001 - $250,000 on 25 Aug 2026. That is 66 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $1,001 - $15,000 on 7 Aug 2026. That is 84 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Quest Diagnostics (DGX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Jonathan Jackson bought Guardant Health (GH) (jointly held), worth $15,001 - $50,000 on 28 Sep 2026. That is 32 days before publication. Filed 19 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“CareDx Raises Guidance on Strong Q3 Test Volume Growth, Revenue Per Test” scores 12 out of 100. The score uses 1 sources.